Issue: Volume XI No. 16 - November 22, 2004

Medicare’s New Policy May Help Labs

ONCE AGAIN, THE DARK REPORT IS FIRST TO ALERT YOU to a significant development in the laboratory testing marketplace. I am referring to a new and evolving Medicare policy which calls for the agency to reimburse for expensive new medical treatments and diagnostic tests. As you will read on pages 14-15, this policy has two …

Medicare’s New Policy May Help Labs Read More »

Big Seattle Med Center Adopts “Lean” Methods

CEO SUMMARY: Laboratory and pathology services at Virginia Mason Medical Center are an integral part of its hospital-wide Lean quality management initiative. Because of the importance of lab test data to so many clinical services, the laboratory often finds itself making key contributions in the process improvement efforts mounted by such clinical services as the …

Big Seattle Med Center Adopts “Lean” Methods Read More »

CA, FL, BC Move Forward With Lab Test Contracts

CEO SUMMARY: Medicaid agencies in the bellwether states of California and Florida continue to push ahead with plans to revise laboratory test contract policies. In British Columbia, private laboratory companies face an uncertain future as the provincial health administration maneuvers to upset the laboratory contracting status quo. It’s a trend with the potential to be …

CA, FL, BC Move Forward With Lab Test Contracts Read More »

Medicare Changes Policy On New Med Procedures

CEO SUMMARY: Faced with a literal tidal wave of new medical procedures, new therapeutic drugs, and new diagnostic tests, Medicare is crafting a unique strategy. As a new clinical option reaches the market, Medicare will reimburse—but only if the patient participates in a clinical study and these studies are paid for by either vendors or …

Medicare Changes Policy On New Med Procedures Read More »

Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente

KEVIN JOHNSON AND VIJAY AGGARWAL JOIN AUREON BIOSCIENCES TWO VETERAN LAB EXECUTIVES are back in the business. Kevin Johnson is now the Chairman at Aureon Biosciences Corporation and Vijay Aggarwal, Ph.D. is President and CEO. The fact that both men chose to join Aureon Biosciences will draw attention to the biotech firm. It is developing …

Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente Read More »

“November 22, 2004 Intelligence: Late Breaking Lab News”

Community-based pathologists get a featured role on the Learning Channel’s Inside Health program. It will be aired Sunday, November 28 at 8:30 am EST. The Learning Channel used pathologists affiliated with Pathology Service Associates (PSA) to help create a segment on the role of pathology in healthcare. PSA plans to make a video of the …

“November 22, 2004 Intelligence: Late Breaking Lab News” Read More »

;